Search alternatives:
ppm decrease » _ decrease (Expand Search), a decrease (Expand Search), pa decreased (Expand Search)
nn decrease » _ decrease (Expand Search), a decrease (Expand Search), mean decrease (Expand Search)
mg decrease » _ decrease (Expand Search), a decrease (Expand Search), mean decrease (Expand Search)
we decrease » _ decrease (Expand Search), a decrease (Expand Search), mean decrease (Expand Search)
50 nn » 50 ns (Expand Search), 50 ng (Expand Search), 50 n (Expand Search)
Showing 81 - 100 results of 75,014 for search '(( 5 ppm decrease ) OR ((( 50 nn decrease ) OR ( 10 ((mg decrease) OR (we decrease)) ))))', query time: 1.46s Refine Results
  1. 81
    OJS decreases locomotor activity and increases sleep time during the night cycle in the AOM/DSS model.

    OJS decreases locomotor activity and increases sleep time during the night cycle in the AOM/DSS model. by Patrice Cunningham (12914917)

    Published 2022
    Save to List
    Saved in:
  2. 82
    Flowchart of study selection.

    Flowchart of study selection. by Alejandro Piscoya (782326)

    Published 2020
    Subjects:
    Save to List
    Saved in:
  3. 83
    Effect of remdesivir on invasive ventilation at 14 days.

    Effect of remdesivir on invasive ventilation at 14 days. by Alejandro Piscoya (782326)

    Published 2020
    Subjects:
    Save to List
    Saved in:
  4. 84
    Effect of remdesivir on all-cause mortality at 14 days.

    Effect of remdesivir on all-cause mortality at 14 days. by Alejandro Piscoya (782326)

    Published 2020
    Subjects:
    Save to List
    Saved in:
  5. 85
    Summary of findings table for the comparison remdesivir 5 days vs. standard of care for hospitalized, moderate COVID-19.

    Summary of findings table for the comparison remdesivir 5 days vs. standard of care for hospitalized, moderate COVID-19. by Alejandro Piscoya (782326)

    Published 2020
    Subjects:
    Save to List
    Saved in:
  6. 86
    Description of characteristics of included studies.

    Description of characteristics of included studies. by Alejandro Piscoya (782326)

    Published 2020
    Subjects:
    Save to List
    Saved in:
  7. 87
    Fig 10 -

    Fig 10 - by Koffi Djaman (3374105)

    Published 2024
    Save to List
    Saved in:
  8. 88
    ReaxFF Reactive Force Field for Exploring Electronically Switchable Polarization in Zn<sub>1–<i>x</i></sub>Mg<sub><i>x</i></sub>O Ferroelectric Semiconductors

    ReaxFF Reactive Force Field for Exploring Electronically Switchable Polarization in Zn<sub>1–<i>x</i></sub>Mg<sub><i>x</i></sub>O Ferroelectric Semiconductors by Alireza Sepehrinezhad (19199048)

    Published 2024
    “…We also observe a strong temperature dependence of the coercive field in Zn<sub>1–<i>x</i></sub>Mg<sub><i>x</i></sub>O, with values decreasing as the temperature increases. …”
    Save to List
    Saved in:
  9. 89
    Complete data.

    Complete data. by Jan Víteček (11434774)

    Published 2024
    Save to List
    Saved in:
  10. 90
    Fig 4 -

    Fig 4 - by Jan Víteček (11434774)

    Published 2024
    Save to List
    Saved in:
  11. 91
    Supplementary Material for: SGLT2 inhibitors decrease overhydration and proteasuria in patients with chronic kidney disease: a longitudinal observational study

    Supplementary Material for: SGLT2 inhibitors decrease overhydration and proteasuria in patients with chronic kidney disease: a longitudinal observational study by Schork A. (17795387)

    Published 2024
    “…Results: 42 patients (29 % with diabetic/hypertensive CKD, 31 % with IgA nephropathy; 88 % dapagliflozin 10 mg, 10 % dapagliflozin 5 mg, 2 % empagliflozin 20 mg; median eGFR 46 mL/min/1.73m² and albuminuria 1911 mg/g creatinine) participated in the study. …”
    Save to List
    Saved in:
  12. 92
    Supplementary Material for: SGLT2 inhibitors decrease overhydration and proteasuria in patients with chronic kidney disease: a longitudinal observational study

    Supplementary Material for: SGLT2 inhibitors decrease overhydration and proteasuria in patients with chronic kidney disease: a longitudinal observational study by Schork A. (17795387)

    Published 2024
    “…Results: 42 patients (29 % with diabetic/hypertensive CKD, 31 % with IgA nephropathy; 88 % dapagliflozin 10 mg, 10 % dapagliflozin 5 mg, 2 % empagliflozin 20 mg; median eGFR 46 mL/min/1.73m² and albuminuria 1911 mg/g creatinine) participated in the study. …”
    Save to List
    Saved in:
  13. 93
    Chlorophyll content in L10 after 42 days of treatment.

    Chlorophyll content in L10 after 42 days of treatment. by Baolin Kan (12936933)

    Published 2022
    Save to List
    Saved in:
  14. 94
    DataSheet1_Physiologically Based Pharmacokinetic Modeling in Pregnant Women Suggests Minor Decrease in Maternal Exposure to Olanzapine.docx

    DataSheet1_Physiologically Based Pharmacokinetic Modeling in Pregnant Women Suggests Minor Decrease in Maternal Exposure to Olanzapine.docx by Liang Zheng (206933)

    Published 2022
    Save to List
    Saved in:
  15. 95
    Table_1_Trans ε-Viniferin Decreases Amyloid Deposits With Greater Efficiency Than Resveratrol in an Alzheimer’s Mouse Model.pdf

    Table_1_Trans ε-Viniferin Decreases Amyloid Deposits With Greater Efficiency Than Resveratrol in an Alzheimer’s Mouse Model.pdf by Aline Freyssin (11912204)

    Published 2022
    Save to List
    Saved in:
  16. 96
    Image_1_Trans ε-Viniferin Decreases Amyloid Deposits With Greater Efficiency Than Resveratrol in an Alzheimer’s Mouse Model.pdf

    Image_1_Trans ε-Viniferin Decreases Amyloid Deposits With Greater Efficiency Than Resveratrol in an Alzheimer’s Mouse Model.pdf by Aline Freyssin (11912204)

    Published 2022
    Save to List
    Saved in:
  17. 97
    Image_3_Trans ε-Viniferin Decreases Amyloid Deposits With Greater Efficiency Than Resveratrol in an Alzheimer’s Mouse Model.pdf

    Image_3_Trans ε-Viniferin Decreases Amyloid Deposits With Greater Efficiency Than Resveratrol in an Alzheimer’s Mouse Model.pdf by Aline Freyssin (11912204)

    Published 2022
    Save to List
    Saved in:
  18. 98
    Image_2_Trans ε-Viniferin Decreases Amyloid Deposits With Greater Efficiency Than Resveratrol in an Alzheimer’s Mouse Model.pdf

    Image_2_Trans ε-Viniferin Decreases Amyloid Deposits With Greater Efficiency Than Resveratrol in an Alzheimer’s Mouse Model.pdf by Aline Freyssin (11912204)

    Published 2022
    Save to List
    Saved in:
  19. 99
    Table_2_Trans ε-Viniferin Decreases Amyloid Deposits With Greater Efficiency Than Resveratrol in an Alzheimer’s Mouse Model.pdf

    Table_2_Trans ε-Viniferin Decreases Amyloid Deposits With Greater Efficiency Than Resveratrol in an Alzheimer’s Mouse Model.pdf by Aline Freyssin (11912204)

    Published 2022
    Save to List
    Saved in:
  20. 100
    Image_4_Trans ε-Viniferin Decreases Amyloid Deposits With Greater Efficiency Than Resveratrol in an Alzheimer’s Mouse Model.pdf

    Image_4_Trans ε-Viniferin Decreases Amyloid Deposits With Greater Efficiency Than Resveratrol in an Alzheimer’s Mouse Model.pdf by Aline Freyssin (11912204)

    Published 2022
    Save to List
    Saved in:

Search Tools: